Omalizumab Appears to Decrease Bronchoalveolar Lavage Matrix Metalloproteinases in Severe Allergic Asthma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Omalizumab on Bronchoalveolar Lavage Matrix Metalloproteinases in Severe Allergic Asthma
J Asthma 2021 Mar 25;[EPub Ahead of Print], W Zastrzeżyńska, S Bazan-Socha, M Przybyszowski, A Gawlewicz-Mroczka, B Jakieła, H Plutecka, L Zaręba, J Musiał, K Okoń, K Sładek, J SojaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.